trending Market Intelligence /marketintelligence/en/news-insights/trending/yysl3klfe0l4zvo-4aqtdw2 content esgSubNav
In This List

Destiny Pharma chairman to step down; replacement named

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


Destiny Pharma chairman to step down; replacement named

Destiny Pharma PLC said Nigel Rudd is stepping down as chairman and a member of its board Dec. 31.

Rudd will be replaced by Nick Rodgers, a nonexecutive director of Destiny Pharma, in the chairman role.

Brighton, U.K.-based Destiny Pharma develops and sells medicines for infectious diseases.